AI assistant
CONMED Corp — Director's Dealing 2019
Apr 9, 2019
31971_dirs_2019-04-09_73aa9577-86b2-4466-8a67-f2bc0d5fe3c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-04-08
Reporting Person: Kuyper Dirk (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-04-08 | Common Stock | M | 1000 | $33.43 | Acquired | 13906 | Direct |
| 2019-04-08 | Common Stock | F | 406 | $82.38 | Disposed | 13500 | Direct |
| 2019-04-08 | Common Stock | M | 1000 | $39.64 | Acquired | 14500 | Direct |
| 2019-04-08 | Common Stock | F | 482 | $82.38 | Disposed | 14018 | Direct |
| 2019-04-08 | Common Stock | M | 1000 | $55.70 | Acquired | 15018 | Direct |
| 2019-04-08 | Common Stock | F | 677 | $82.38 | Disposed | 14341 | Direct |
| 2019-04-08 | Common Stock | S | 2000 | $83.39 | Disposed | 12341 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-04-08 | Sars (Stock Appreciation Rights) | $33.43 | M | 1000 | Disposed | 2023-07-26 | Common Stock (1000) | Direct |
| 2019-04-08 | Sars (Stock Appreciation Rights) | $39.64 | M | 1000 | Disposed | 2024-09-11 | Common Stock (1000) | Direct |
| 2019-04-08 | Sars (Stock Appreciation Rights) | $55.70 | M | 1000 | Disposed | 2025-06-01 | Common Stock (1000) | Direct |
Footnotes
F1: The exercise reported in this Form 4 was effected pursuant to a rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
F2: The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
F3: The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
F4: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
F5: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.
F6: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service.